Angus Wilson

Title: Innovations by Angus Wilson in RNA Virus Therapy

Introduction

Angus Wilson is an accomplished inventor based in New York, NY (US). He has made significant contributions to the field of virology, particularly in the development of therapeutic methods for RNA virus infections. His innovative approach focuses on modulating the Type I interferon pathway to combat these infections effectively.

Latest Patents

Angus Wilson holds a patent titled "Targeting RNA viruses using inhibitors of METTL3." This patent outlines methods for prophylaxis or therapy for RNA virus infections. The methods involve modulating the Type I interferon pathway in RNA virus-infected cells of an individual. The pathway is modulated by administering one or more agents that inhibit the expression and/or function of METTL3 or inhibit the expression and/or function of YTHDF1, YTHDF2, or YTHDF3. He has 1 patent to his name.

Career Highlights

Angus Wilson is affiliated with New York University, where he conducts research and develops innovative solutions for viral infections. His work has garnered attention for its potential impact on public health and disease management.

Collaborations

Angus collaborates with notable colleagues, including Ian J Mohr and Hannah Burgess. Their combined expertise enhances the research efforts and contributes to the advancement of therapeutic strategies against RNA viruses.

Conclusion

Angus Wilson's innovative work in targeting RNA viruses represents a significant advancement in therapeutic methods. His contributions to the field are poised to make a lasting impact on the treatment of viral infections.